Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy

Nilotinib, a tyrosine kinase inhibitor, has been studied extensively in various tumor models; however, no information exists about the pharmacological action of nilotinib in bacterial infections. Mycobacterium bovis (M. bovis) and Mycobacterium avium subspecies paratuberculosis (MAP) are the etiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Tariq, Zhao, Deming, Shah, Syed Zahid Ali, Sabir, Naveed, Wang, Jie, Liao, Yi, Song, Yinjuan, Dong, Haodi, Hussain Mangi, Mazhar, Ni, Jiamin, Yang, Lifeng, Zhou, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562972/
https://www.ncbi.nlm.nih.gov/pubmed/31130711
http://dx.doi.org/10.3390/cells8050506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562972/
https://www.ncbi.nlm.nih.gov/pubmed/31130711
http://dx.doi.org/10.3390/cells8050506

Ejemplares similares